Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Flachenecker

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis and Related Disorders|October 8, 2021
Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany - A registry-based/multicentric cohort studyNiklas Frahm, David Ellenberger, Firas Fneish, et al.
Wiener Medizinische Wochenschrift (1946)|February 2, 2022
[New master's program: multiple sclerosis management]Isabel Voigt, Christine Stadelmann, Sven G Meuth, et al.
Fortschritte Der Neurologie-Psychiatrie|July 28, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Fortschritte Der Neurologie-Psychiatrie|October 16, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Scientific Reports|June 26, 2021
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registryLisa-Marie Ohle, David Ellenberger, Peter Flachenecker, et al.
Multiple Sclerosis and Related Disorders|August 11, 2018
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosisDavid Ellenberger, Kerstin Eichstädt, Peter Flachenecker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2018
Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registryPaulus Stefan Rommer, Kerstin Eichstädt, David Ellenberger, et al.
Neurological Research and Practice|May 18, 2025
From routine to selective: how updated MRI guidelines reshape gadolinium use in GermanyMarc Pawlitzki, Alexander Stahmann, Niklas Frahm, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2021
Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis RegistryStefan J Blaschke, David Ellenberger, Peter Flachenecker, et al.
Multiple Sclerosis and Related Disorders|June 21, 2020
Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithmBurkhard Domurath, Ines Kurze, Ruth Kirschner-Hermanns, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis and Related Disorders|October 8, 2021
Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany - A registry-based/multicentric cohort studyNiklas Frahm, David Ellenberger, Firas Fneish, et al.
Wiener Medizinische Wochenschrift (1946)|February 2, 2022
[New master's program: multiple sclerosis management]Isabel Voigt, Christine Stadelmann, Sven G Meuth, et al.
Fortschritte Der Neurologie-Psychiatrie|July 28, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Fortschritte Der Neurologie-Psychiatrie|October 16, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Scientific Reports|June 26, 2021
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registryLisa-Marie Ohle, David Ellenberger, Peter Flachenecker, et al.
Multiple Sclerosis and Related Disorders|August 11, 2018
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosisDavid Ellenberger, Kerstin Eichstädt, Peter Flachenecker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2018
Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registryPaulus Stefan Rommer, Kerstin Eichstädt, David Ellenberger, et al.
Neurological Research and Practice|May 18, 2025
From routine to selective: how updated MRI guidelines reshape gadolinium use in GermanyMarc Pawlitzki, Alexander Stahmann, Niklas Frahm, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2021
Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis RegistryStefan J Blaschke, David Ellenberger, Peter Flachenecker, et al.
Multiple Sclerosis and Related Disorders|June 21, 2020
Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithmBurkhard Domurath, Ines Kurze, Ruth Kirschner-Hermanns, et al.
Pageof 7